Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Upstream Bio, Inc. UPB

Set alert

Price alert · UPB

All alert types
3.41 USD +0.14 +4.28%

At close · Oct 30

3.35 -0.06 -1.76%

After hours · Oct 30, 4:44 PM ET

Bid
3.40 × 2
Ask
3.41 × 2
3.15 Day range 3.43
2.74 52-week range 32.60
YTD
-87.44%
1 year
-86.77%
Open
3.26
Prev close
3.27
Mkt cap
186.77M
Vol
946.13K
Avg vol
846.31K
EPS
-2.88
P/E
0.00
Div yield
0.00%
More statistics
Low
3.15
High
3.43
Forward P/E
-2.45
Beta
0.00
Short ratio
2.45
Inst. own
94.73%
Dividend
0.00
Ex-div date
50-d avg
18.55
200-d avg
19.11
1y target
47.86

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for UPB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

8.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 4

Valuation

P/E -10.2×
FY 2022: -33.3×FY 2023: -21.0×FY 2024: -11.0×FY 2025: -10.2×
FY 2022 5y median -16.0× FY 2025
P/S 512×
FY 2022: 659×FY 2023: 336×FY 2024: 356×FY 2025: 512×
FY 2022 5y median 434× FY 2025
P/B 4.3×
FY 2022: -7.5×FY 2023: -6.5×FY 2024: 1.8×FY 2025: 4.3×
FY 2022 5y median -2.3× FY 2025
P/FCF -11.0×
FY 2022: -41.8×FY 2023: -21.0×FY 2024: -14.1×FY 2025: -11.0×
FY 2022 5y median -17.6× FY 2025
EV/EBITDA -9.5×
FY 2022: -32.8×FY 2023: -37.8×FY 2024: -8.3×FY 2025: -9.5×
FY 2022 5y median -21.1× FY 2025
EV/Sales 477×
FY 2022: 645×FY 2023: 325×FY 2024: 219×FY 2025: 477×
FY 2022 5y median 401× FY 2025
FCF Yield -9.1%
FY 2022: -2.4%FY 2023: -4.8%FY 2024: -7.1%FY 2025: -9.1%
FY 2022 5y median -5.9% FY 2025

Profitability

Gross Margin 100.0%
FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2022 5y median 100.0% FY 2025
Operating Margin -5618.8%
FY 2022: -1972.7%FY 2023: -1685.5%FY 2024: -3281.2%FY 2025: -5618.8%
FY 2022 5y median -2626.9% FY 2025
Net Margin -5026.0%
FY 2022: -1969.3%FY 2023: -862.9%FY 2024: -2650.0%FY 2025: -5026.0%
FY 2022 5y median -2309.7% FY 2025
ROE -42.2%
FY 2022: 22.5%FY 2023: 16.7%FY 2024: -13.4%FY 2025: -42.2%
FY 2022 5y median 1.7% FY 2025
ROIC -47.0%
FY 2022: -174.4%FY 2023: -36.2%FY 2024: -16.5%FY 2025: -47.0%
FY 2022 5y median -41.6% FY 2025
ROA -40.5%
FY 2022: -129.2%FY 2023: -17.5%FY 2024: -13.0%FY 2025: -40.5%
FY 2022 5y median -29.0% FY 2025

Growth (YoY)

Revenue 20.4%
FY 2022: 0.0%FY 2023: 96.4%FY 2024: -0.4%FY 2025: 20.4%
FY 2022 FY 2025
Operating Income -106.2%
FY 2022: 0.0%FY 2023: -67.8%FY 2024: -93.9%FY 2025: -106.2%
FY 2022 FY 2025
EPS (diluted) -78.5%
FY 2022: 0.0%FY 2023: -59.1%FY 2024: -41.9%FY 2025: -78.5%
FY 2022 FY 2025
Free Cash Flow -123.3%
FY 2022: 0.0%FY 2023: -99.3%FY 2024: -56.8%FY 2025: -123.3%
FY 2022 FY 2025

Financial Health

Current Ratio 26.2×
FY 2022: 3.8×FY 2023: 18.0×FY 2024: 44.6×FY 2025: 26.2×
FY 2022 5y median 22.1× FY 2025
Quick Ratio 26.2×
FY 2022: 3.8×FY 2023: 18.0×FY 2024: 44.6×FY 2025: 26.2×
FY 2022 5y median 22.1× FY 2025
Debt / Equity 0.0×
FY 2022: -0.0×FY 2023: -0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2022: 0.7×FY 2023: 1.3×FY 2024: 5.2×FY 2025: 0.7×
FY 2022 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2022 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31